Mankind Pharma Limited (BOM:543904)

India flag India · Delayed Price · Currency is INR
2,578.00
+34.60 (1.36%)
At close: Jul 11, 2025
22.53%
Market Cap 1.05T
Revenue (ttm) 122.07B
Net Income (ttm) 19.91B
Shares Out n/a
EPS (ttm) 49.20
PE Ratio 52.74
Forward PE 49.95
Dividend n/a
Ex-Dividend Date n/a
Volume 98,657
Average Volume 29,034
Open 2,559.00
Previous Close 2,543.40
Day's Range 2,550.00 - 2,679.00
52-Week Range 1,910.10 - 3,050.00
Beta n/a
RSI 68.06
Earnings Date Jul 31, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m... [Read more]

Industry Pharmaceutical Preparations
Founded 1991
Employees 19,540
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543904
Full Company Profile

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.12% compared to the previous year's 103.35 billion. Earnings were 19.91 billion, an increase of 4.08%.

Financial Statements

News

There is no news available yet.